美国招商投资网
美国国旗
强生创新全球生态系统联系人名录67—2
来源:网群国际    浏览:

Innovation Accelerating a World Without Disease The World Without Disease Accelerator (WWDA) is a unique enterprise R&D group aligned with global commercial expertise andfocused on the discovery, development and delivery of disruptive products/technologies, business models and partnerships to advance the elimination of disease. The WWDA brings together distinct enabling capabilities in areas including the microbiome, immunosciences,predictive analytics and behavioral sciences to seed transformative growth opportunities and catalyze a paradigm shift in prevention,interception and cure strategies and solutions.

 

Building on the 130-year legacy of Johnson & Johnson blending heart, science and ingenuity to tackle some of today’s most pressing public health challenges, we believe that all people - no matter where they live - deserve access to lifesaving innovation at the same time.

Public HealthJOHNSON & Charting a bold, new, self-sustainable approach,Johnson & Johnson Global Public Health is pushing boundaries as the frst fully-dedicated organization within a healthcare company working to ensure that innovative treatments and technologies are available,affordable and accessible for the world’s most underserved populations.

 

Combining R&D, novel access programs and business model innovation, in-country operations, and the power of multi-sectoral partnerships we are committed to unlocking the power of science to move beyond incremental improvement to achieve transformational outcomes and solve for HIV, tuberculosis and other high burden diseases which disproportionately impact people in low income countri***

To achieve that we seek to partner within and outside Johnson & Johnson Family of Companies to deliver on the promise of improved health for all, everywhere.

 

TB Expanding access and uptake of existing regimens for multidrugresistant TB (MDR-TB), developing simplifed treatment regimens and novel molecular approaches; companion diagnostics.

Novel and simplifed treatment tools, including new formulations,point-of-care diagnostics and others; innovative prevention tools andstrategies, including vaccines, microbicides and other education/ empowerment programs.

 

OTHERS Nontuberculous mycobacterial lung disease (NTM); Dengue prevention and treatment; Malaria prevention and treatment; Chagas disease; Obstetric fstula repair; preterm birth prevention; maternal/newborn survival; general surgery and trauma; pandemic preparedness and emerging threats (e.g., Ebola, Zika, etc.).

 

Connect With Us

External Innovation Contacts

 

External Innovation

William N. Hait, M.D., Ph.D.

Global Head, Johnson & Johnson

External Innovation

E: jnjinnovation**[ta]**.jnj.com

 

Strategic Investing

Tom Heyman

President, JJDC

E: info-jjdc**[ta]**.jnj.com

 

Company Incubation

Melinda Richter

Global Head, JLABS

E: jlabs**[ta]**.jnj.com

 

Innovation Center San Francisco,

California, USA

Rowan Chapman, Ph.D.

Head, Johnson & Johnson Innovation,

West North America and Australia

E: jnjinnovation**[ta]**.jnj.com

 

Innovation Center Shanghai, China

Dan Wang, M.D., MBA, MPH

Head, Johnson & Johnson Innovation,

APAC (Asia Pacifc)

E: jnjinnovation**[ta]**.jnj.com

 

Innovation Center London, UK

Sir Harpal Kumar, Dsc, MEng, MBA

Head, Johnson & Johnson Innovation,

EMEA (Europe, Middle East and Africa)

E: jnjinnovation**[ta]**.jnj.com

 

Innovation Center Boston, USA

Michal Preminger, Ph.D., MBA

Head, Johnson & Johnson Innovation,

East North America

E: jnjinnovation**[ta]**.jnj.com

 

Lung Cancer Initiative

Avrum Spira, M.D., M.S.C.

Global Head, Lung Cancer Initiative

E: aspira**[ta]**.jnj.com

 

World Without Disease Accelerator

Ben Wiegand

Global Head, WWDA

E: bwiegan**[ta]**.jnj.com

 

Global Public Health

Jaak Peeters

Global Head, Global Public Health

E: gph**[ta]**.jnj.com

 

Health Technology

Oliver Hsiang

Global Head, Health Technology Partnerships

& Corporate Development

E: ohsiang**[ta]**.jnj.com

 

Janssen R&D Leadership Contacts

 

Cardiovascular & Metabolism

James F. List, M.D., Ph.D.

Global Therapeutic Head,

Cardiovascular & Metabolism

Janssen Research & Development

Mathai Mammen, M.D., Ph.D.

Global Head, Research & Development

EARLY STAGE - J&J INNOVATION

Mark Erion, Discovery

E: merion**[ta]**.jnj.com

 

Thomas Gustafson, West US & ANZ

E: tgustaf5**[ta]**.jnj.com

 

Jim Tobin, East US

E: jtobin3**[ta]**.jnj.com

 

Shamina Rangwala, Europe

E: srangwal**[ta]**.jnj.com

 

LATE STAGE - JBD

Sarah Brennan

E: sbrennan**[ta]**.jnj.com

 

Scott Lundeen, Scientifc Licensing

E: slundeen**[ta]**.jnj.com

 

Oncology

Peter Lebowitz, M.D., Ph.D.

Global Therapeutic Head, Oncology

 

EARLY STAGE - J&J INNOVATION

Joseph Erhardt, Discovery

E: jerhardt**[ta]**.jnj.com

 

Sylvaine Cases, West US & ANZ

E: scases**[ta]**.jnj.com

 

Bob Radinsky, East US

E: rradinsk**[ta]**.jnj.com

 

Sonal Patel, Eur***

E: spate203**[ta]**.jnj.com

 

Stefan Hart, Asia Pacifc

E: shart16**[ta]**.jnj.com

 

LATE STAGE - JBD

Deborah Watson

E: dwatson4**[ta]**.jnj.com

 

Mike Rycyzyn, Scientifc Licensing

E: mrycyzyn**[ta]**.jnj.com

 

Immunology

David M. Lee, M.D., Ph.D.

Global Therapeutic Head, Immunology

EARLY STAGE - J&J INNOVATION

Ian Anderson, Discovery

E: ianders7**[ta]**.jnj.com

 

Jackie Benson, West US & ANZ

E: jbenson4**[ta]**.jnj.com

 

Michael Elliott, East US

E: melliot2**[ta]**.jnj.com

 

LATE STAGE - JBD

Johan Verbeeck

E: jverbee2**[ta]**.jnj.com

 

Simon Blake, Scientifc Licensing

E: sblake5**[ta]**.jnj.com

 

Discovery and Platforms

Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development

& Supply (DPDS)

Beth Hill

E: bhill4**[ta]**.jnj.com

 

Trevor Howe, Europe

E: thowe4**[ta]**.jnj.com

 

Julian Bertschinger

E: jbertsc**[ta]**.jnj.com

 

Neuroscience

Husseini K. Manji, M.D., F.R.C.P.C.

Global Therapeutic Head, Neuroscience

EARLY STAGE - J&J INNOVATION

David Bredt, Discovery

E: dbredt**[ta]**.jnj.com

 

Guy Seabrook, West US & AZ

E: gseabroo**[ta]**.jnj.com

 

Eric Schaeffer, East US

E: eschaef7**[ta]**.jnj.com

 

Declan Jones, Europe

E: djone119**[ta]**.jnj.com

 

John Issac, Europe

E: jisaac5**[ta]**.jnj.com

 

LATE STAGE - JBD

Lucinda Warren

E: cwarren4**[ta]**.jnj.com

 

Gregor Macdonald, Scientifc Licensing

E: gmacdon1**[ta]**.jnj.com

 

Infectious Diseases & Vaccines

James Merson, Ph.D.

Global Therapeutic Head, Infectious Diseases

Johan Van Hoof, M.D.

Global Therapeutic Head, Vaccines

EARLY STAGE - J&J INNOVATION

Debbie Law, Discovery

E: dlaw2**[ta]**.jnj.com

 

Kenneth Simmen, Global (Europe focused)

E: ksimmen1**[ta]**.jnj.com

 

Nicola La Monica, US & ANZ

E: nlamonic**[ta]**.jnj.com

 

LATE STAGE - JBD

Marianne De Backer

E: mdbacker**[ta]**.jnj.com

 

Philippe Alen, Scientifc Licensing

E: palen**[ta]**.jnj.com

 

Pulmonary Hypertension

Martin Fitchet, M.D.

Global Therapeutic Head, Pulmonary Hypertension

LATE STAGE - JBD

Nicolas Franco

E: nfranco9**[ta]**.jnj.com

 

Joerg Laeuffer, Scientifc Licensing

E: jlaeuff1**[ta]**.jnj.com

 

Data Science

Troy Sarich, Janssen R&D Strategy

E: tsarich**[ta]**.jnj.com

 

Najat Khan, Janssen R&D Strategy

E: nkhan31**[ta]**.jnj.com

 

Joseph Lehar, Oncology

E: jlehar**[ta]**.jnj.com

 

Guna Rajagopal, Genomics

E: grajagop**[ta]**.jnj.com

 

Vaibhav Narayan, Neuroscience

E: vnaray16**[ta]**.jnj.com

 

Emma Huang, J&J Innovation

E: bhuang26**[ta]**.jnj.com

 

Janssen Business Development

Patrick Verheyen

Global Head, Janssen Business Development

 

Global Public Health

Wim Parys, M.D.

Head R&D, Global Public Health

Jens Bitsch-Norhave

E: jbitschn**[ta]**.jnj.com

 

Johan Verbeeck

E: jverbee2**[ta]**.jnj.com

 

Consumer R&D Leadership and Business Development Contacts

 

Global Consumer R&D

Josh Ghaim, Ph.D.

Chief Technology Offcer,

Johnson & Johnson Family of Consumer Companies

Fabiana Gargaro

VP, Global Femcare R&D Deployment (LATAM)

Consumer R&D Franchise Leaders

 

Consumer R&D Regional Leaders

Anna Prilutsky

VP, Global Baby R&D

Jonathan Miller

VP, Global Oral Care/Wound Care R&D

Jennifer Zhu

VP, Global Beauty R&D

Stephen Raven

VP, Global Self-Care and

R&D Deployment (EMEA)

Adam Ricciardone

VP, R&D Deployment (Asia Pacifc)

Mona Nair

VP, Global eCommerce New Initiatives & R&D

Deployment (North America)

 

Consumer External Innovation

John Bell

VP, External Innovation & Business Models

EARLY STAGE - J&J INNOVATION

Stephanie Robertson

Senior Director, Consumer Scientifc

Innovation (West US)

E: srober18**[ta]**.jnj.com

 

Stefanie Dhanda

Senior Director, Scientifc Innovation,

Consumer (East US)

E: sdhanda**[ta]**.jnj.com

 

Elena Fernandez-Kleinlein

Senior Director, Scientifc Innovation,

Consumer (Europe)

E: efernkle**[ta]**.jnj.com

 

Tyrone Mao

Senior Director, Scientifc Innovation,

Consumer (Asia Pacifc)

E: tmao2**[ta]**.jnj.com

 

Consumer Business Development

Peter Kerrane

Worldwide VP, Strategy & Business Development

E: pkerrane**[ta]**.jnj.com

 

Brian Shuster

VP, Consumer Business Development

E: bshuster**[ta]**.jnj.com

 

Medical Devices R&D Leadership and Business Development Contacts

 

Medical Devices R&D

Peter Shen, Ph.D.

Global Head of Research & Development,

Johnson & Johnson Medical Devices Companies

Medical Devices Business Development

Susan Morano

Global Head of Business Development,

Johnson & Johnson Medical Devices Companies

Medical Devices R&D Heads

Euan Thomson

Global Head, Digital Technologies

and Advanced Innovation

Beth McCombs

Vice President, R&D, Ethicon

Rob Laird

Vice President, R&D, DePuy Synthes

Avi Shalgi

Vice President, R&D, Cardiovascular

& Specialty Solutionst

 

Jennifer Kozac

VP, Business Development, New Growth Platforms

E: jkozak**[ta]**.jnj.com

 

Noam Krantz

WW VP, Business Development, Ethicon

E: nkrantz**[ta]**.jnj.com

 

Christine Knoblauch

VP, Business Development, DePuy Synthes

E: cknobla2**[ta]**.jnj.com

 

Biren Mehta

VP, Business Development, Cardiovascular

& Specialty Solutions

E: bmehta5**[ta]**.jnj.com

 

Vision R&D Leadership and Business Development Contacts

 

Vision R&D

Xiao-Yu Song, M.D., Ph.D.

Global Head of Research & Development,

Johnson & Johnson Vision

 

Vision Business Development

JD Moore

Global Head of Business Development,

Johnson & Johnson Vision

 

Troy Wu

Senior Director, Business Development, Surgical

E: twu29**[ta]**.jnj.com

 

Matthew Rieke

Senior Director, Business Development, Surgical

E: mrieke**[ta]**.jnj.com

 

Tonja Danowski

VP, Business Development, Vision Care

E: tcurtis2**[ta]**.jnj.com

 

Vision R&D Heads

David Turner

Head of R&D, Contact Lens Platform

Griffth Altmann

Head of R&D, Surgical Instrumentation

Manohar Raheja

Head of R&D, Ophthalmic Implant Platform

Randall Pugh

Head of Smart Device Technology

Vision External Innovation

EARLY STAGE - J&J INNOVATION

Leonard Borrmann

Head of External Innovation (West US)

E: lborrman**[ta]**.jnj.com

 

Hassan Chaouk

Director of External Innovation (East US)

E: hchaouk**[ta]**.jnj.com

 

EMAIL US:

jnjinnovation**[ta]**.jnj.com

 

FOLLOW US ON TWITTER:

**[ta]JNJInnovation

VISIT OUR WEBSITE FOR MORE INFORMATION:

HTTP://**jinnovation.com

HTTP://**bs.jnjinnovation.com

APPLY FOR A CHALLENGE:

HTTP://**nnovation.com/challenges

Johnson & Johnson Innovation, LLC ***

 

项目合作:18361148798    或 点击这里给我发消息
温馨提示:本站提供免费发布服务,但对信息的合法性、实时性、真实性和完整性,不承担任何责任。名录资源由会员为向全球展示品牌形象上传,个人信息均经处理后发布,如有遗漏戓涉嫌侵权他人及不愿展示形象的,请将“该页网址和需修改及删除的内容”发至本站邮箱戓留言给我们处理。凡注册会员并发布信息或名录资源的,均可定期获得全球项目参考及合作机会。本站名录资源概不对任何第三方开放,更不提供如交换、出售及查询等服务!
项目合作及建议请留言:请理性留言,并遵守相关规定
姓名: 手机: QQ号: 微信: 邮箱:
验证码 点此换一张
关于我们 招商培训 代理招商 代理投资 代理融资 代理政策 战略伙伴 服务外包
广告报价 汇款方式 合作方式 免费发布 网群建设 诚聘英才 网站导航 设为首页